WESTCLIFF MEDICINES LIMITED

Company limited by guarantee

Company Registration Number:
08037424 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2024

Period of accounts

Start date: 01 April 2023

End date: 31 March 2024

WESTCLIFF MEDICINES LIMITED

Company limited by guarantee

Contents of the Financial Statements

for the Period Ended 31 March 2024

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

WESTCLIFF MEDICINES LIMITED

Company limited by guarantee

Company Information

for the Period Ended 31 March 2024




Registered office: 7
Poole Road
Bournemouth
Dorset
BH2 5QR
Company Registration Number: 08037424 (England and Wales)

WESTCLIFF MEDICINES LIMITED

Company limited by guarantee

Balance sheet

As at 31 March 2024


Notes

2024
£

2023
£
Fixed assets
Intangible assets: 4 0 0
Tangible assets: 5 39,844 45,558
Total fixed assets: 39,844 45,558
Current assets
Stocks: 35,225 35,225
Debtors: 140,882 177,651
Cash at bank and in hand: 261,231 59,308
Total current assets: 437,338 272,184
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 395,874 ) ( 266,150 )
Net current assets (liabilities): 41,464 6,034
Total assets less current liabilities: 81,308 51,592
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 81,308 51,592

The notes form part of these financial statements

WESTCLIFF MEDICINES LIMITED

Company limited by guarantee

Balance sheet continued

As at 31 March 2024


Notes

2024
£

2023
£
Reserves
Revaluation reserve: 6 81,308 51,592
Members funds 81,308 51,592

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 23 December 2024
And Signed On Behalf Of The Board By:

Name: Martin Uhelak
Status: Director

The notes form part of these financial statements

WESTCLIFF MEDICINES LIMITED

Company limited by guarantee

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

WESTCLIFF MEDICINES LIMITED

Company limited by guarantee

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 8 7

WESTCLIFF MEDICINES LIMITED

Company limited by guarantee

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 3. Off balance sheet disclosure

    No

WESTCLIFF MEDICINES LIMITED

Company limited by guarantee

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 4. Intangible assets

    Total
    Cost £
    At 01 April 2023 0
    Additions 0
    Disposals (0)
    Revaluations 0
    Transfers 0
    At 31 March 2024 0
    Amortisation
    Amortisation at 01 April 2023 0
    Charge for year 0
    On disposals (0)
    Other adjustments 0
    Amortisation at 31 March 2024 0
    Net book value
    Net book value at 31 March 2024 0
    Net book value at 31 March 2023 0

WESTCLIFF MEDICINES LIMITED

Company limited by guarantee

Notes to the Financial Statements

for the Period Ended 31 March 2024

5. Tangible Assets

Total
Cost £
At 01 April 2023 156,760
Additions 1,866
Disposals (0)
Revaluations 0
Transfers 0
At 31 March 2024 158,626
Depreciation
At 01 April 2023 111,202
Charge for year 7,580
On disposals -
Other adjustments -
At 31 March 2024 118,782
Net book value
At 31 March 2024 39,844
At 31 March 2023 45,558

WESTCLIFF MEDICINES LIMITED

Company limited by guarantee

Notes to the Financial Statements

for the Period Ended 31 March 2024

6. Revaluation reserve


2024
£
Balance at 01 April 2023 51,592
Surplus or deficit after revaluation 29,716
Balance at 31 March 2024 81,308